 
|
Pancreatic Cancer News and Archives
For access to the
Select Abstractssm section, please click here
For educational purposes
only; not to be relied upon. Please read Pancreatica Disclaimer
- 2008
Second Quarter
-
-
- A Phase I Pharmacokinetic
Study of Hypoxic Abdominal Stop-Flow Perfusion with Gemcitabine
in Patients with Advanced Pancreatic Cancer and Refractory Malignant
Ascites
June 28, 2008
- ...more
-
- PET/CT Fusion Scan Enhances
CT Staging in Patients with Pancreatic Neoplasms
June 13, 2008
- ...more
-
- Selective Hepatic arterial
Infusion of In-111-DTPA-Phe(1)-Octreotide in Neuroendocrine Liver
Metastases
June 7, 2008
- ...more
-
- Neoadjuvant Radiation is
Associated with Improved Survival in Patients with Resectable
Pancreatic Cancer: An Analysis of Data from the Surveillance,
Epidemiology, and End Results (SEER) Registry
June 4, 2008
- ...more
-
- Phase I Trial of the Human
Immunodeficiency Virus Protease Inhibitor Nelfinavir and Chemoradiation
for Locally Advanced Pancreatic Cancer
June 1, 2008
- ...more
-
- Radioembolization for Unresectable
Neuroendocrine Hepatic Metastases Using Resin 90Y-Microspheres:
Early Results in 148 Patients
June 1, 2008
- ...more
-
- Short Time to Progression
under First-Line Chemotherapy Is a Negative
Prognostic Factor for Time to Progression and Residual Survival
under
Second-Line Chemotherapy in Advanced Pancreatic Cancer
May 23, 2008
- ...more
-
- Survival in Familial Pancreatic
Cancer
May 22, 2008
- ...more
-
- Prospective Phase II Trial
of Neoadjuvant Chemotherapy with Gemcitabine
and Cisplatin for Resectable Adenocarcinoma of the Pancreatic
Head
May 20, 2008
- ...more
-
- Risk Factors Associated with
Neuroendocrine Tumors: A U.S.-Based
Case-Control Study
May 19, 2008
- ...more
-
- COX-2 Inhibition is Neither
Necessary nor Sufficient for Celecoxib to Suppress Tumor Cell
Proliferation and Focus Formation in Vitro
May 16, 2008
- ...more
-
- Radiolabeled DOTATOC in Patients
with Advanced Paraganglioma and
Pheochromocytoma
May 16, 2008
- ...more
-
- Clinical Significance and
Regulation of the Costimulatory Molecule B7-H1
in Pancreatic Cancer
May 15, 2008
- ...more
-
- Response to a Third-Line
Mitomycin C (MMC)-Based Chemotherapy in a
Patient with Metastatic Pancreatic Adenocarcinoma Carrying Germline
BRCA2 Mutation
May 8, 2008
- ...more
-
- Evaluating the Impact of
a Single-Day Multidisciplinary Clinic on the
Management of Pancreatic Cancer
May 7, 2008
- ...more
-
- Primary Tumour Resection
in Metastatic Nonfunctioning Pancreatic
Endocrine Carcinomas
May 5, 2008
- ...more
-
- A Long-Term Survival Case
of Unresectable Malignant Pancreatic Endocrine
Tumor Successfully Treated with Systemic Chemotherapy
May 1, 2008
- ...more
-
- Borderline Resectable Pancreatic
Cancer: The Importance of this Emerging
Stage of Disease
May 1, 2008
- ...more
-
- Free-from-Progression Period
and Overall Short Preoperative Immunotherapy with IL-2 Increases
the Survival of Pancreatic Cancer Patients Treated with Macroscopically
Radical Surgery
May 1, 2008
- ...more
-
- Interferon-Alpha Restitutes
the Chemosensitivity in Pancreatic Cancer
May 1, 2008
- ...more
-
- Surgery and Radiofrequency
Ablation for Treatment of Liver Metastases
from Midgut and Foregut Carcinoids and Endocrine Pancreatic Tumors
May 1, 2008
- ...more
-
- Treatment with the Radiolabeled
Somatostatin Analog [177 Lu-DOTA
0,Tyr3]Octreotate: Toxicity, Efficacy, and Survival
May 1, 2008
- ...more
-
- Comparison Between (68)Ga-DOTA-NOC
and (18)F-DOPA PET for the Detection
of Gastro-Entero-Pancreatic and Lung Neuro-Endocrine Tumours
April 17, 2008
- ...more
-
- Oral Capecitabine in Gemcitabine-Pretreated
Patients with Advanced
Pancreatic Cancer
April 17, 2008
- ...more
-
- Gemcitabine Chemotherapy
and Single-Fraction Stereotactic Body
Radiotherapy for Locally Advanced Pancreatic Cancer
April 1, 2008
- ...more
-
- 6-L-18F-Fluorodihydroxyphenylalanine
PET in Neuroendocrine Tumors: Basic Aspects
- and Emerging Clinical Applications
April 1, 2008
- ...more
-
- A Phase I Trial of Arterial
Infusion Chemotherapy with Gemcitabine and
5-Fluorouracil for Unresectable Advanced Pancreatic Cancer after
Vascular Supply Distribution Via Superselective Embolization
April 1, 2008
- ...more
-
- A Phase II Study Evaluating
Bevacizumab in Combination with Fixed-Dose Rate
- Gemcitabine and Low-Dose
Cisplatin for Metastatic Pancreatic Cancer: Is an
- Anti-VEGF Strategy Still
Applicable?
April 1, 2008
- ...more
-
- Brucea Javanica Fruit Induces
Cytotoxicity and Apoptosis in Pancreatic
Adenocarcinoma Cell Lines
April 1, 2008
- ...more
-
- Gemcitabine plus Celecoxib
in Patients with Advanced or Metastatic
Pancreatic Adenocarcinoma: Results of a Phase II Trial
April 1, 2008
- ...more
-
- Lapatinib/Gemcitabine and
Lapatinib/Gemcitabine/Oxaliplatin: A Phase I Study for Advanced
Pancreaticobiliary Cancer
April 1, 2008
- ...more
-
- PEFG (Cisplatin, Epirubicin,
5-Fluorouracil, Gemcitabine) Regimen as
Second-Line Therapy in Patients with Progressive or Recurrent
Pancreatic
Cancer after Gemcitabine-Containing Chemotherapy
April 1, 2008
- ...more
-
- Requiem for the Term 'Carcinoid
Tumour' in the Gastrointestinal Tract?
April 1, 2008
- ...more
-
- What Constitutes a "High-Volume"
Hospital for Pancreatic Resection?
April 1, 2008
- ...more
|
